Related Experiment Video
Updated: May 7, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Pathophysiology of immune-mediated demyelinating neuropathies--Part II: Neurology
Hessel Franssen1, Dirk C G Straver
1Department of Neurology and Neurosurgery, Brain Center Rudolf Magnus, University Medical Center Utrecht, Heidelberglaan 100, 3584, CX Utrecht, The Netherlands.
Abstract:
In the second part of this review we deal with the clinical aspects of immune-mediated demyelinating neuropathies. We describe the relationship between pathophysiology and symptoms and discuss the pathophysiology of specific disease entities, including Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor neuropathy, anti-myelin-associated glycoprotein neuropathy, and POEMS syndrome.
Related Concept Videos
Encephalitis ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology
Myasthenia Gravis ll: Pathophysiology
Type I Diabetes II: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Multiple Sclerosis l: Introduction

